NCT03216811View on ClinicalTrials.gov

Nutraceutical in Cardiovascular Primary Prevention

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

December 2, 2017

Conditions
Hypercholesterolemia
Interventions
DRUG

nutraceutical

8-week administration of nutraceutical compound

Trial Locations (1)

44124

University Hospital of Ferrara, Cona

All Listed Sponsors
lead

University Hospital of Ferrara

OTHER

NCT03216811 - Nutraceutical in Cardiovascular Primary Prevention | Biotech Hunter | Biotech Hunter